NCT07560540 Nutritional Intervention Implication in Enhanced Recovery After Surgery for Whipple Procedure
| NCT ID | NCT07560540 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Veterinary and Animal Sciences, Lahore - Pakistan |
| Condition | Pancreatic Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-12-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this research is to assess the impact of personalized nutritional intervention on postoperative complications and length of stay in Whipple's patients via assessing the parameters related to body composition, nutritional status, weight maintenance, biochemical profile (LFTs, RFTs, CBC, CRP, serum electrolytes, coagulation profile and HbA1c) and muscle preservation postoperatively. Moreover, enhanced recovery after surgery (ERAS) guidelines in Whipple's patients will also be monitored. Exactly 20 patients undergoing Whipple's Procedure/PPPD in 1 year will be recruited for the study. Medical nutrition therapy will include energy intake of 25- 30 Kcal/kg body weight and protein 1.2-1.5g/kg body weight. Enteral nutrition and parenteral nutrition will be given accordingly. After discharge, patients receiving chemotherapy and patients not receiving chemotherapy will be nutritionally intervened accordingly. Follow-ups will be done in the 2nd week, 3rd month and 6th month after surgery. Data will be analyzed using SPSS version 27. To assess the significant difference among study groups t-test, repeated measure analysis of variance (ANOVA) and regression model will be applied. The level of significance will be kept at 5%. t-test for treatment groups.
Eligibility Criteria
Inclusion Criteria: * Malignancy of; * Distal common bile duct * Pancreatic head * Periampullary * Duodenal * Patients scheduled for elective Whipple's procedure (laparoscopic and open) * Age 18 and above Exclusion Criteria: * Patients undergoing Whipple's procedure for reasons other than malignancy * Patients undergoing emergency procedures * Patients with significant preoperative complications prohibiting oral intake * Age below 18
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07560540 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07560540 currently recruiting?
Yes, NCT07560540 is actively recruiting participants. Contact the research team at javeriyaafzal23@gmail.com for enrollment information.
Where is the NCT07560540 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07560540 clinical trial?
NCT07560540 is sponsored by University of Veterinary and Animal Sciences, Lahore - Pakistan. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.